|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 49.52 USD | +3.06% |
|
+23.31% | +66.12% |
| 06-09 | TG Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 02:00 PM | |
| 06-09 | TG Therapeutics Begins Phase 2 Myasthenia Gravis Trial | MT |
| Market Cap | 7.02B 6.06B 5.59B 5.23B 9.8B 667B 9.95B 65.95B 25.72B 325B 26.34B 25.78B 1,124B | P/E Ratio 2026 * |
36.2x | P/E Ratio 2027 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 7.06B 6.1B 5.62B 5.26B 9.86B 671B 10.01B 66.38B 25.88B 327B 26.51B 25.95B 1,132B | EV / Sales 2026 * |
7.51x | EV / Sales 2027 * | 5.26x |
| Free-Float |
88.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: TG Therapeutics, Inc.
| 1 day | +3.06% | ||
| 1 week | +23.31% | ||
| Current month | +30.52% | ||
| 1 month | +21.40% | ||
| 3 months | +77.11% | ||
| 6 months | +57.96% | ||
| Current year | +66.12% |
| 1 week | 41.55 |  | 50.41 |
| 1 month | 36.48 | | 50.41 |
| Current year | 26.76 | | 50.41 |
| 1 year | 25.28 | | 50.41 |
| 3 years | 6.46 | | 50.41 |
| 5 years | 3.48 | | 50.41 |
| 10 years | 3.32 | | 56.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 60 | 2011-12-28 |
Sean Power
DFI | Director of Finance/CFO | 44 | 2011-12-28 |
Jenna A. Bosco
IRC | Investor Relations Contact | - | 2011-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Weiss
CHM | Chairman | 60 | 2011-12-28 |
Laurence Charney
BRD | Director/Board Member | 79 | 2012-02-29 |
Yann Echelard
BRD | Director/Board Member | 62 | 2012-11-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-27 | Don | Director | 43,197 | 0.0272% | ||
| 01-07 | Free | Chief Executive Officer | 622,000 | 0.3918% | ||
| 01-07 | Free | Chief Financial Officer | 90,000 | 0.0567% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.06% | +23.31% | +37.52% | +82.19% | 7.02B | |
| -2.41% | +0.14% | +38.28% | +153.06% | 1,010B | |
| +1.07% | +3.48% | +53.32% | +49.09% | 580B | |
| +1.32% | +0.22% | +19.18% | +67.17% | 402B | |
| +0.77% | 0.00% | +21.28% | +19.14% | 330B | |
| +0.44% | +3.48% | +25.65% | +36.16% | 281B | |
| -0.85% | -2.86% | +22.54% | +16.96% | 280B | |
| +1.66% | +1.20% | -44.35% | -47.35% | 197B | |
| +0.32% | +1.61% | +20.32% | +59.80% | 192B | |
| -0.22% | -2.76% | +14.19% | +61.12% | 156B | |
| Average | +0.52% | +3.09% | +20.79% | +49.73% | 343.6B | |
| Weighted average by Cap. | -0.22% | +1.08% | +27.79% | +70.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 941M 813M 749M 701M 1.31B 89.45B 1.33B 8.84B 3.45B 43.54B 3.53B 3.46B 151B | 1.24B 1.07B 987M 924M 1.73B 118B 1.76B 11.65B 4.54B 57.36B 4.65B 4.55B 199B |
| Net income | 217M 187M 173M 161M 303M 20.6B 307M 2.04B 794M 10.03B 814M 796M 34.72B | 429M 371M 342M 320M 599M 40.8B 609M 4.03B 1.57B 19.86B 1.61B 1.58B 68.77B |
| Net Debt | 45.42M 39.23M 36.15M 33.84M 63.41M 4.32B 64.4M 427M 166M 2.1B 170M 167M 7.28B | -492M -425M -392M -367M -687M -46.8B -698M -4.63B -1.8B -22.78B -1.85B -1.81B -78.88B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 49.52 $ | +3.06% | 2,548,926 |
| 26-06-11 | 48.05 $ | +3.07% | 2,531,683 |
| 26-06-10 | 46.62 $ | +7.49% | 5,113,192 |
| 26-06-09 | 43.37 $ | +5.91% | 2,587,686 |
| 26-06-08 | 40.95 $ | +1.97% | 1,555,890 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TGTX Stock
Select your edition
All financial news and data tailored to specific country editions
